Screening large “libraries” of compounds to find those with a desired biological activity is a powerful method for discovering new drugs, but requires a large, expensive and dedicated facility.
Now, scientists at the Florida campus of The Scripps Research Institute (TSRI) have devised the central component of a screening system that would be orders of magnitude smaller and cheaper.
“We’ve developed a device that can do the functional equivalent of high-throughput compound screening on an ultra-miniaturized scale,” said the study’s principal investigator Brian M. Paegel, an associate professor at TSRI.
The advance, published recently online ahead of print in Analytical Chemistry, follows a previous study from the Paegel laboratory in ACS Combinatorial Science that described the synthesis of miniaturized DNA-encoded compound libraries. The new screening device is designed to work with the new type of library.
Current high-throughput screening systems typically occupy 10,000 square feet of space or more and cost millions of dollars. They rely heavily on robotic devices that retrieve compounds from the library, place each compound into a separate small well in an “assay microplate” and measure each compound’s biological activity—for example, whether the compound inhibits a particular enzyme involved in viral replication.
Being almost entirely automated and relatively quick, such systems can rapidly screen the tens or hundreds of thousands of compounds in a typical library. But the great cost of these high-throughput screening systems limits their use to locations at pharmaceutical companies and large research institutions. The Scripps Florida campus houses one of the most active high-throughput screening facilities outside the pharmaceutical industry.
The new approach starts with the use of “one-bead-one-compound” (OBOC) libraries, in which individual compounds are chemically attached to microscopic beads. Over the past two decades, many laboratories have begun to work with OBOC libraries of one type or another, which are so quickly and cheaply prepared and are so compact that such libraries are essentially laboratory consumables.
“It is possible to generate an OBOC library of millions of compounds in a week for about $500,” said Alexander K. Price, a senior research associate in the Paegel laboratory and lead author of the new study.
There are considerable technical challenges involved in putting bead-borne compounds through miniature screening devices. But, as they report in their new paper, Paegel and Price were able to engineer a benchtop-scale device that meets these challenges and can screen OBOC libraries.
The device is built on the microfluidics principles that also underlie inkjet printer technology. Using a “suspension hopper,” which Paegel and Price described in a 2014 Analytical Chemistry paper, the device introduces OBOC library beads into tiny liquid droplets that contain the assay of interest, such as an enzymatic activity assay. The volume of these assay droplets is about 100,000 times less than the volumes used for high-throughput screening assays.
The device then frees each compound from its bead with a photochemical reaction induced by ultraviolet (UV) light and, after an appropriate period of incubation, records the result in each droplet.
Dubbed LIGHTSABR (Light-Induced and Graduated High-Throughput Screening After Bead Release) for its light-based cleavage of compounds from their carrier beads, the device overcomes significant technical hurdles concerning the smooth flow of droplets, the absorption of stray UV irradiation and calibration of the UV waveguide.
A key innovation is that the technique allows users to vary the UV illumination to adjust the amount of a compound cleaved from its bead—and thus adjust the dose of the compound being tested. The team successfully demonstrated this dosing function using an assay designed to find inhibitors of HIV-1 protease, a key enzyme involved in the replication of the virus that causes AIDS.
The next step for Paegel and Price is to apply the microfluidic LIGHTSABR and the laboratory’s DNA-encoded OBOC libraries. “In addition to antiviral compounds, we are also pursuing new antibiotics and other drug classes that address the emergence of resistance in rapidly evolving pathogens,” said Paegel.
“Hundreds of laboratories around the world could operate their own miniaturized screening facilities, using their own assays to go after targets that are of most interest to them,” said Price.
The Latest on: Portable Drug-Discovery System
via Google News
The Latest on: Portable Drug-Discovery System
- Seeking a Research Scientist (20W58)on October 7, 2020 at 11:29 pm
Taking advantage of their unique properties as moldable, portable water, together with the elaboration ... This position falls under the specialized duties discretionary work system; one working day ...
- Worldwide 3D Scanner Industry to 2024 - An Increase in Adoption of Portable Handheld Scanners is Driving the Market - ResearchAndMarkets.comon October 6, 2020 at 5:30 am
The market is driven by the increase in adoption of portable handheld scanners and government support for 3D scanning technology. The 3D scanner market analysis includes technology segment, end-user ...
- One Up Your Brushing with a Sleek, Portable Solution from Philips Sonicareon October 1, 2020 at 7:21 am
STAMFORD, Conn., Oct. 1, 2020 /PRNewswire/ -- Philips launches Philips One by Sonicare, the new battery-operated power toothbrush developed for those who are ready for a step up from manual brushing.
- Bantec Expands Covid-19 Disinfecting Product Offerings with Portable UVC Units, Light Fixtures and More Under New Electronics Distributor Agreementon October 1, 2020 at 5:12 am
Some of these products include portable industrial UV sanitation lights (kills 99% of viruses), UVC handheld surface sanitizer, UV disinfecting desk lights, rechargeable disinfectant door lights ...
- Harnessing novel CRISPR systems for genome engineeringon September 30, 2020 at 6:30 am
These tools, including the popular genome editing system CRISPR, allow for unprecedented manipulation ... and the sensitive, specific, and portable diagnostic platform SHERLOCK. He is one of the first ...
- Follow the Money: $100M to DNAnexus, Investments in Machine-Learning for Drug Discovery, Moreon September 16, 2020 at 5:00 pm
insitro, a San Francisco machine-learning driven drug discovery and development company ... Lewis and Clark AgriFood, and Lupa Systems. $100M: Cloud-Based Informatics Platform DNAnexus, Mountain View, ...
- UC San Diego Health Revives Non-Beating Donor Heart for Successful Transplantationon September 15, 2020 at 2:37 pm
UC San Diego Health is the first hospital on the West Coast to perform heart transplant surgery from a donor after circulatory death, or DCD, using a new portable organ care system. The successful ...
- Flow Cytometry: Fluidics and Versatility in Flowon September 12, 2020 at 12:17 am
For users, manipulation of this flowing stream via the fluidics system is the central point of control ... flow cytometry is adaptable to high-throughput screening (HTS) and drug discovery in ways ...
via Bing News